Related Experiment Video

Updated: May 9, 2026

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
12:49

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Published on: March 21, 2020

Evaluation of peripheral matrix metalloproteinase-1 in Parkinson's disease: a case-control study

Vineeta Gupta1, Manish Kumar Singh, Ravindra Kumar Garg

  • 11Department of Pharmacology & Therapeutics, King George's Medical University , Lucknow, Uttar Pradesh , India.

The International Journal of Neuroscience
|July 16, 2013
PubMed
Abstract

Insights

Serum levels of matrix metalloproteinase-1 (MMP-1) were significantly lower in Parkinson's disease (PD) patients compared to healthy controls. This finding suggests a potential role for MMP-1 in PD pathogenesis, particularly in females.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Pathology

Background:

  • Matrix metalloproteinases (MMPs), particularly MMP-1, are key enzymes in extracellular matrix (ECM) remodeling.
  • Dysregulation of ECM components is increasingly recognized in neurodegenerative diseases like Parkinson's disease (PD).

Purpose of the Study:

  • To investigate and compare circulating levels of MMP-1 in individuals with Parkinson's disease and healthy controls.
  • To explore potential correlations between MMP-1 levels and clinical parameters in PD.

Main Methods:

  • Serum samples from Parkinson's disease patients and matched healthy controls were analyzed.
  • Enzyme-linked immunosorbent assay (ELISA) was employed to quantify MMP-1 concentrations.

Main Results:

  • Parkinson's disease patients exhibited significantly lower serum MMP-1 levels compared to controls (p = 0.005).
  • A statistically significant, albeit weak, positive correlation was observed between MMP-1 levels and disease duration (r = 0.36, p = 0.02).
  • The reduction in MMP-1 was more pronounced in female PD patients.

Conclusions:

  • Circulating MMP-1 levels are significantly reduced in Parkinson's disease patients.
  • The observed lower MMP-1 levels may indicate altered ECM dynamics in PD.
  • Sex-specific differences in MMP-1 levels warrant further investigation in Parkinson's disease.

More Related Videos

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease16:57

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model06:07

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

Published on: June 23, 2023

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...